Hoppa till huvudinnehållet
Till KTH:s startsida

Publikationer av Veronique Chotteau

Refereegranskade

Artiklar

[2]
I. F. Pinto, V. Chotteau och A. Russom, "Microfluidic Cartridge for Bead-Based Affinity Assays," Methods in Molecular Biology, vol. 2804, s. 127-138, 2024.
[3]
L. Dewasme, M. Mäkinen och V. Chotteau, "Multivariable robust tube-based nonlinear model predictive control of mammalian cell cultures," Computers and Chemical Engineering, vol. 183, 2024.
[5]
L. Dewasme, M. Mäkinen och V. Chotteau, "Practical data-driven modeling and robust predictive control of mammalian cell fed-batch process," Computers and Chemical Engineering, vol. 171, 2023.
[6]
M. Pappenreiter et al., "Product sieving of mAb and its high molecular weight species in different modes of ATF and TFF perfusion cell cultures," Journal of chemical technology and biotechnology (1986), vol. 98, no. 7, s. 1658-1672, 2023.
[17]
N. A. Brechmann et al., "Proof-of-Concept of a Novel Cell Separation Technology Using Magnetic Agarose-Based Beads," MAGNETOCHEMISTRY, vol. 8, no. 3, s. 34, 2022.
[19]
D. Rodrigues et al., "An Integrated Approach for Modeling and Identification of Perfusion Bioreactors via Basis Flux Modes," Computers and Chemical Engineering, vol. 149, 2021.
[20]
N. A. Brechmann et al., "Antibody capture process based on magnetic beads from very high cell density suspension," Biotechnology and Bioengineering, vol. 118, no. 9, s. 3499-3510, 2021.
[23]
G. Bastin, V. Chotteau och A. Vande Wouwer, "Metabolic flux analysis of VERO cells under various culture conditions," Processes, vol. 9, no. 12, 2021.
[25]
L. Zhang et al., "Probabilistic model by Bayesian network for the prediction of antibody glycosylation in perfusion and fed-batch cell cultures," Biotechnology and Bioengineering, vol. 118, no. 9, s. 3447-3459, 2021.
[26]
S. Särnlund, Y. Jiang och V. Chotteau, "Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch," Biotechnology and Bioengineering, vol. 118, no. 9, s. 3533-3544, 2021.
[27]
[28]
[30]
[37]
[38]
L. Zamani et al., "High Cell Density Perfusion Culture has a Maintained Exoproteome and Metabolome," Biotechnology Journal, vol. 13, no. 10, 2018.
[39]
M. Leino et al., "Human embryonic stem cell dispersion in electrospun PCL fiber scaffolds by coating with laminin-521 and E-cadherin-Fc," Journal of Biomedical Materials Research. Part B - Applied biomaterials, vol. 106, no. 3, s. 1226-1236, 2018.
[43]
L. Al-Khalili et al., "Characterization of Human CD133+Cells in Biocompatible Poly(l-lactic acid) Electrospun Nano-Fiber Scaffolds," Journal of Biomaterials and Tissue Engineering, vol. 6, no. 12, s. 959-966, 2016.
[45]
H. A. Oddsdottir et al., "Robustness analysis of elementary flux modes generated by column generation," Mathematical Biosciences, vol. 273, s. 45-56, 2016.
[47]
Y. Zhang et al., "Very high cell density perfusion of CHO cells anchored in a non-woven matrix-based bioreactor," Journal of Biotechnology, vol. 213, s. 28-41, 2015.
[48]
[49]

Konferensbidrag

[51]
Y. Wang et al., "Model-based Medium Optimization Methodologies in High-cell Density Perfusion Culture," i Cell Culture Engineering XVIII, Cancun, Mexico, April 23-28 2023, 2023.
[53]
K. Colin, H. Hjalmarsson och V. Chotteau, "Gaussian process modeling of macroscopic kinetics : a better-tailored kernel for Monod-type kinetics," i 10th Vienna International Conference on Mathematical Modelling MATHMOD 2022 Vienna Austria, 27–29 July 2022, 2022, s. 397-402.
[55]
M. Wang et al., "Estimation of Heteroscedastic Multilinear Systems," i Proceedings of the IEEE Conference on Decision and Control, 2020, s. 2875-2880.
[56]
M. Wang et al., "Unscented Bayes Methods for Hierarchical Gaussian Processes," i 2020 Australian and New Zealand control conference (ANZCC 2020), 2020, s. 137-142.
[57]
M. Wang et al., "A multi-step least-squares method for nonlinear rational models," i Proceedings of the American Control Conference, 2019, s. 4509-4514.
[58]
V. Chotteau och A. Lindqvist, "Study of the effect of high pH and alkali addition in a cultivation of Chinese Hamster Ovary cell," i Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), 2012, s. 323-326.
[59]
V. Chotteau och H. Hjalmarsson, "Tuning of dissolved oxygen and pH PID control parameters in large scale bioreactor by lag control," i Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), 2012, s. 327-330.
[60]
M.-F. Clincke et al., "Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™," i BMC Proceedings, 2011, Volume 5, Supplement 8, P105, 2011, s. 105.
[61]
V. Chotteau och H. Hjalmarsson, "Tuning of dissolved oxygen and pH PID control parameters in large scale bioreactor by lag control," i Proceedings of the Cell Culture Engineering XI Conference, 2008.

Kapitel i böcker

[62]
V. Chotteau, "Perfusion Processes," i Animal Cell Culture, Mohamed Al-Rubeai red., Switzerland Springer : Springer, 2015, s. 407-443.

Icke refereegranskade

Artiklar

[63]
B. Ladd och V. Chotteau, "Suspension Like Scalability of AAV9 Production in Adherent Cells," Molecular Therapy, vol. 31, no. 4, s. 721-721, 2023.
[65]
M. Malm et al., "Improving targeting and yield of AAV by capsid and cell engineering," Human Gene Therapy, vol. 32, no. 19-20, s. A119-A120, 2021.
[66]
A. Karadagi et al., "Human Hepatocyte Spheroids Show Plasticity-enabling Extended Culture and Pretransplant Conditioning," Transplantation, vol. 103, no. 9, s. S5-S5, 2019.
[67]
J. G. Fons et al., "Small scale end-to-end mAb platform with a continuous, integrated and compact process," Abstracts of Papers of the American Chemical Society, vol. 257, 2019.
[68]
A. Castan et al., "Cultivation process intensification utilizing a WAVE Bioreactor (TM) for perfusion cell cultures," Abstracts of Papers of the American Chemical Society, vol. 245, 2013.

Konferensbidrag

[69]
M.-F. Clincke et al., "Perfusion of an IgG producing CHO cell line at very high cell density by ATF or by TFF in WAVE Bioreactor™," i Bioprocessing Summit, Boston, MA, USA, Aug. 22-25, 2011 - Optimizing Cell Culture Technology, 2011.
[70]
M.-F. Clincke et al., "Perfusion of an IgG producing CHO cell line at very high cell density by ATF or by TFF in WAVE Bioreactor™," i HansonWade Conference Optimizing Cell Line Performance, July, 26-28, 2011, London, UK, 2011.
[71]
V. Chotteau et al., "Comparison of cultivation in Techne spinner, Bellco spinner, shake flask and T-flask of human embryonic stem cells," i Proceedings of the SBE's Second International Conference on Stem Cell Engineering, 2010.
[73]
Y. Jiang, E. Svensson och V. Chotteau, "Improvement of a CHO Fed-Batch Process by Fortifying with Plant Peptones," i Cells and Culture : ESACT Proceedings, 2010, Volume 4, Part 3, 2010, s. 281-284.
[74]
V. Chotteau et al., "Study of Alternating Tangential Flow filtration for perfusion and harvest in Chinese Hamster Ovary cells cultivation," i Proceedings of the Cell Culture Engineering Conference XII, April 25-30, 2010, Banff, Canada, 2010.
[75]
V. Chotteau, C. Wåhlgren och H. Pettersson, "Effect of Peptones and Study of Feeding Strategies in a CHO Based Fed-batch Process for the Production of a Human Monoclonal Antibody," i Cell Technology for Cell Products : Proceedings of the 19th ESACT Meeting, Harrogate, UK, June 5-8, 2005, 2007, s. 371-374.

Kapitel i böcker

[76]
V. Chotteau, Y. Zhang och M.-F. Clincke, "Very High Cell Density in Perfusion of CHO Cells by ATF, TFF, Wave Bioreactor, and/or CellTank Technologies : Impact of Cell Density and Applications," i Continuous Processing in Pharmaceutical Manufacturing, Ganapathy Subramanian red., Germany Weinheim : Wiley-VCH Verlagsgesellschaft, 2014, s. 339-356.

Övriga

Patent

Patent

[93]
V. Chotteau et al., "Flexible bag for cultivation of cells," us 20140011270A1, 2011.
Senaste synkning med DiVA:
2024-11-17 02:21:29